Sklavenitis-Pistofidis R, Lightbody ED, Reidy M, et al. Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.08.01.551480